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Abstract 
ePPOC is a program that aims to improve services and outcomes for people experiencing persistent pain. 
It involves specialist pain services collecting a standard set of information to measure outcomes for their 
patients as a result of treatment. Pain services use the information to triage, monitor and plan treatment 
for individual clients, and also send non-identifiable information to ePPOC for analysis. The results of 
these analyses are fed back to participating services every six months, allowing pain management 
services to assess their results, and compare their patients, services and outcomes to other pain 
management services. ePPOC also uses the information collected by services for national benchmarking 
and to develop a coordinated approach to research into the management of chronic pain in Australasia. 
ePPOC is an initiative of the Faculty of Pain Medicine, established with funding from the New South Wales 
Ministry of Health, and supported by key stakeholder bodies. It was launched in 2013 with a small number 
of pain management services trialling the measures and processes. All other pain management services 
throughout Australia and New Zealand are now able to participate. 
PaedePPOC addresses the differing needs of the paediatric pain management sector. This program 
allows collection of data items and assessment tools specific to the needs of children, adolescents and 
their parents. 
This report presents data collected by participating pain management units during 2018. Sixty seven 
adult and nine paediatric pain management services contributed data for this report. 
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The electronic Persistent Pain Outcomes 
Collaboration (ePPOC)  
ePPOC is a program that aims to improve services and outcomes for people experiencing persistent pain. 
It involves specialist pain services collecting a standard set of information to measure outcomes for their 
patients as a result of treatment. Pain services use the information to triage, monitor and plan treatment 
for individual clients, and also send non-identifiable information to ePPOC for analysis. The results of 
these analyses are fed back to participating services every six months, allowing pain management 
services to assess their results, and compare their patients, services and outcomes to other pain 
management services. ePPOC also uses the information collected by services for national benchmarking 
and to develop a coordinated approach to research into the management of chronic pain in Australasia. 
ePPOC is an initiative of the Faculty of Pain Medicine, established with funding from the New South Wales 
Ministry of Health, and supported by key stakeholder bodies. It was launched in 2013 with a small number of 
pain management services trialling the measures and processes. All other pain management services 
throughout Australia and New Zealand are now able to participate. 
PaedePPOC addresses the differing needs of the paediatric pain management sector. This program allows 
collection of data items and assessment tools specific to the needs of children, adolescents and their parents. 
 
This report 
This report presents data collected by participating pain management units during 2018. Sixty seven 
adult and nine paediatric pain management services contributed data for this report (see Appendix A). 
The map below shows the locations of these services. 
This report includes; 
• Information on over 30,000 patients 
• Information on patients’ demographic 
and clinical characteristics and the 
care they received 
• Outcomes for adult and paediatric 
patients who completed an episode of 
treatment 
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Pain management services participating in 
ePPOC 
The services submitting data for this report were both public and private services located in: 
• New South Wales (18 adult and 3 paediatric services) 
• Victoria (17 adult and 2 paediatric services) 
• Queensland (6 adult and 2 paediatric services) 
• Western Australia (3 adult services) 
• South Australia (3 adult and 1 paediatric services) 
• New Zealand (20 adult and 1 paediatric services). 
Since the first ePPOC report in 2014, the number of data-submitting services has increased from 12 to 76. 
 
Figure 1 – Number of data submitting services, 2014-2018 
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Adults referred for pain management  
Demographic profile 
Adult pain management services contributed data for 31,530 patients during 2018. Of these patients, 
57% were female, with an average age of 51 years at the time of referral. Males were slightly younger on 
average at 50 years. The distribution by gender and age is shown in Figure 2.  
 
Figure 2 – Age at referral and gender distribution of patients 
 
Most patients were born in Australia (53%) or New Zealand (22%) and 4% identified as being of 
Aboriginal and/or Torres Strait Islander origin. A relatively small proportion (4%) required an interpreter 
and 8% required assistance with written or spoken communication. Most patients were referred to the 
pain management service by a general practitioner or nurse practitioner (53%).  
The majority of patients were unable to work, either due to pain (39%) or another condition (12%). 18% 
of episodes involved a compensation claim. Figure 3 shows the work status of patients at referral to the 
pain management service.  
 
Figure 3 – Work status of patients at referral 
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Clinical characteristics at referral 
Most patients referred to pain management services completed a questionnaire prior to their first 
appointment with the service. These questionnaires asked patients about their pain, medication and 
health care utilisation, and included standard assessment tools which examined mood, cognition, 
physical function and pain interference. More detailed information regarding these tools is provided in 
Appendix B.  
21,364 of these initial questionnaires were completed, providing a picture of the health and clinical 
characteristics of patients referred for specialist pain management.  
Pain 
 
40% of patients had experienced their pain for more 
than five years, and most (86%) described their pain 
as ‘always present’. The events that led to the 
patients’ pain are shown in Table 1. 
The regions where pain is at its worst are shown in 
Figure 4, with the back being the most common 
(43% of patients identified this as the most painful 
site). 14% of patients had pain in one region only, 
with the remainder identifying multiple regions, as 
shown in Figure 5. 
 
 
Figure 4 – Site of patient’s main pain Figure 5 – Number of pain sites 
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Table 1 – Patient-reported cause of pain 
Precipitating event % 
Injury at work/school 25.1 
No obvious cause 14.3 
Injury at home 11.1 
Related to another illness 10.5 
Motor vehicle crash 10.4 
Injury in another setting 9.4 
After surgery 8.4 
Related to cancer 1.2 
Other 9.8 
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The Brief Pain Inventory (BPI) was used to assess the intensity of pain and its interference in activities of 
daily living over the past week. Figure 6 shows that at referral, nearly 1 in 2 people rated their pain as 
severe, and over 60% reported that it severely interfered with daily activities.  
Figure 6 - Proportion of people with severe, moderate and mild pain and pain interference 
 
 
 
Comorbid conditions 
 
 
The patient questionnaires included a 
list of medical conditions, and asked 
patients to indicate which (if any) they 
experienced in addition to their pain. 
39% of patients reported that they had 
a mental health condition, with the 
majority of these people experiencing 
depression. The percent of patients 
with each of these conditions is shown 
in Table 2.  
The clinical complexity of people 
referred to pain management services 
is further illustrated in Figure 7, which 
shows that most people experience at 
least one other condition in addition to 
their pain. 
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Table 2 - Comorbid conditions 
Medical condition Percentage 
Mental health condition 38.8 
Depression 32.7 
Anxiety 18.3 
PTSD 6.1 
Arthritis 30.5 
Heart and circulation problems 23.5 
High blood pressure 15.3 
High cholesterol 4.4 
Muscle, bone and joint problems other than arthritis 20.8 
Digestive problems 17.9 
Respiratory problems 15.8 
Diabetes 7.3 
Neurological problems 6.3 
Liver, kidney and pancreas problems 5.3 
Thyroid problems 5.1 
Cancer 3.6 
Other medical problems 14.5 
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Figure 7 – Distribution of patients by number of comorbidities 
 
 
Body Mass Index 
Figure 8 – Patient BMI 
  
The average Body Mass Index 
(BMI) of patients at referral was 
29.5 (SD=7.6) which lies in the 
Overweight category, but 
bordering on Obese. The 
percentage of patients in each 
BMI category is show in Figure 8. 
 
 
 
 
 
Mood 
The Depression Anxiety and Stress Subscale (short form) was used to assess the mental health of people 
referred for specialist pain management.  Figure 9 shows that 40% of people were experiencing 
extremely severe or severe depression, and over one third reported severe or extremely severe anxiety 
and/or stress.   
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Figure 9 - The proportion of people reporting depression, anxiety and stress at referral 
 
Cognition 
The Pain Self-Efficacy Questionnaire (PSEQ) assesses a patient’s belief that he or she can perform a range 
of activities despite their pain. 
The average score on the PSEQ following referral to the pain services was 21.4 (SD=13.0), a score 
classified as ‘Moderate’ but bordering on severe impairment (identified by scores less than 20). Figure 10 
shows that one in two people reported that pain severely impaired their belief that they could perform 
these daily activities. 
Figure 10 - The proportion of people reporting severe, moderate and mildly impaired pain self-efficacy at referral 
 
 
Patients also completed the Pain Catastrophising Scale (PCS), which measures thoughts and feelings 
related to pain. The average score on the PCS at referral was 27.5 (SD=13.9), a score classified as 
‘Moderate’, but with just under 50% of people reporting severe pain catastrophising (Figure 11). 
Figure 11 - The proportion of people reporting severe and high levels of pain catastrophising at referral 
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Medication use 
At referral to the service, 59% of patients were taking opioid medication on more than two days per 
week. The average daily oral morphine equivalent for patients using opioid medication was 62.9mg. On 
average, patients were using medications from two of the seven major drug groups, identified by the 
Faculty of Pain Medicine as of particular interest in pain management1. The percentage of patients using 
each of the drug groups is show in Figure 12. 
Figure 12 – Percent of patients using each drug group at referral 
 
 
Health service utilisation  
Patients reported how many times in the past three months they used various health services and had 
diagnostic tests performed because of their pain (Table 3). These equate to, on average, one visit every 
week for pain-related reasons. 
Table 3 – Patient use of health services 
 
 
 
 
 
  
                                                                
1 These are opioids, paracetamol, NSAIDS, antidepressants, anticonvulsants, benzodiazepines and 
medicinal cannabinoids. 
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Health service Mean 
General practitioner 4.7 
Medical specialist 1.4 
Health professionals other than doctors  4.7 
Hospital emergency department 0.5 
Hospital admission 0.3 
Diagnostic tests 1.4 
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The episode of care 
The median wait time for a patient to start an episode of care at a pain management service was 55 days 
(average = 92 days). This reflects the time from when the pain service receives a referral, to the patient’s 
first clinical contact. Over two thirds of people were seen within 3 months of the service receiving the 
referral. 
Most episodes of care extended from 1 to 6 months (median = 134 days) and patients typically received 
an average of 25 hours of treatment during that period. 
 
Patient outcomes 
Pain management units provided information on the outcomes of 5,408 patients who completed their 
episode of care during 2018.  
At the end of the episode, patients were asked to compare how they would describe themselves now 
(overall and physical abilities) compared to before receiving treatment. Patients responded using a Likert 
scale which ranged from -3 (very much worse) to +3 (very much better). Responses are shown in Figure 
13, with almost 3 in 4 patients reporting that they had improved following pain management.  
Approximately 1 in 5 reported no change, and 8-9% rated themselves as worse. 
Figure 13 – Global rating of change at episode end – overall and physical 
  
 
Pain, mood and cognitions 
After receiving pain management, a large proportion of people reported clinically significant 
improvement2 in the severity of their pain and its interference in their daily activities, as well as improved 
mood and pain-related cognitions (see Table 4).  
                                                                
2 In assessing outcomes using the standard assessment tools, ePPOC has adopted guidelines for 
determining whether a change is clinically significant, that is, what change in score represents a 
meaningful difference to the patient. These guidelines are detailed in Appendix B. 
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Table 4 - Proportion of people who made clinically significant improvement (CSI) from referral to episode end 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over time, the proportion of people who report clinically significant improvement has increased across all 
domains. This is shown in Figure 14, which displays improvement in 2018 compared to 2015. 
 
Figure 14 – Percentage of patients reporting clinically significant improvement, 2015 vs. 2018 
 
 
 
Medication use 
Following treatment at a pain management service, many people made improvements in their use of 
medications. In particular, of the people who were using opioid medication at referral: 
• 29% no longer used opioid medication frequently (more than two days per week) 
• The average daily morphine equivalent reduced from 57mg to 42mg per day 
• 45% of people were able to at least halve their opioid dose 
• 41% of people who were using high doses of opioid at referral (>40mg per day) were able to 
reduce their dose by at least half following pain management. 
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Employment and work productivity 
Almost one half (42%) of patients who completed an episode of care were unemployed due to pain at 
referral. While the majority were still unemployed due to pain at the end of the episode, 1 in 3 people no 
longer classified themselves in this way – they were either employed (full time or part time), seeking 
employment, not working by choice or unable to work for a reason other than pain (see Figure 15). 
 
Figure 15 – Work status at episode end for patients who were ‘unemployed due to pain’ at referral 
 
For those people who were working at referral, absenteeism and productivity improved following pain 
management. Figure 16 shows that at referral, workers missed over 30% of their usual hours because of 
pain, and rated impairment while working at 56%. After treatment this decreased to 19% missed hours 
and 41% impairment. 
 
Figure 16 - Absenteeism and productivity at referral compared to episode end 
 
Overall work impairment, taking into account absenteeism and impairment while at work, decreased 
from 63% at referral to 46% following treatment at a pain management service.  
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Children and adolescents referred for pain 
management 
Demographic profile 
Participating paediatric pain management services contributed data for 803 patients during 2018. Of 
these patients, 71% were female, with an average age of 12.8 years at the time of referral. Males were 
younger on average at 11.6 years. The distribution by gender and age is shown in Figure 17.  
 
Figure 17 – Age and gender distribution of patients 
 
Most patients were born in Australia (87%) and 5% identified as being of Aboriginal and/or Torres Strait 
Islander origin. Patients were generally referred to the pain management service by a specialist 
practitioner (66%).  
 
Clinical characteristics at referral 
Most children and their parents completed a questionnaire prior to their first appointment with the 
service. These questionnaires asked children and parents about pain, medication and use of health care 
services, and included standard assessment tools which examined pain severity, quality of life, disability, 
pain-related worries and the impact of the child’s pain on the parent. More detailed information 
regarding these tools is provided in Appendix C.  
868 of these initial questionnaires were completed (427 completed by the child, 441 by the parent), 
providing a picture of the health and clinical characteristics of patients following their referral to a 
specialist paediatric pain management service. All information in this section is based on patient and/or 
parent report. 
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Pain 
Parents were asked how long their child’s pain had 
been present, and 60% responded that their child 
had experienced the pain for more than 12 months. 
Most (67%) described the pain as ‘always present’. 
The events thought to have caused the child’s pain 
are shown in Table 6. 40% of parent’s reported that 
the cause of their child’s pain was unknown. 
Regions where the main pain was experienced are 
shown in Figure 18, with the back and head the 
most common (17% each) followed by the 
abdomen (16%). Just over one in four patients had 
pain in one region only, with the remainder 
identifying multiple regions (see Figure 19). 
 
Figure 18 – Site of patient’s main pain Figure 19 – Number of pain sites 
  
   
Pain severity was assessed using the Brief Pain Inventory (BPI) in children aged eight years and above. 
Young children aged 5-7 completed the Faces Pain Scale – Revised. Parents also rated their child’s pain 
using the BPI. The average pain rating reported by child and parent at referral was 5.5 and 5.4 (moderate 
severity), respectively, with one in three children and parents rating the pain as severe.  
 
Figure 20 – Patient and parent ratings of pain severity 
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Table 5 – Event precipitating the patient’s 
pain 
Precipitating event % 
No known cause 39.9 
Injury 21.2 
Illness 15.1 
After surgery 7.7 
Other 16.0 
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Comorbid conditions 
Parents were asked whether their child had a disability and/or other medical condition in addition to 
their pain. The responses are shown in Table 6 below.  
 
Table 6 - Percent of parents reporting disabilities and comorbidities 
Disabilities and comorbid conditions % of patients 
Disabilities  
Sight impairment 5.8 
Hearing impairment 2.4 
Intellectual disability 3.5 
Physical disability 9.3 
Comorbid conditions  
Chronic disease 21.4 
Mental health condition 24.0 
Cancer 1.3 
 
Role functioning 
The number of school days children missed in the previous fortnight (10 school days) as a result of their 
pain increased with age, as shown in Figure 21.  
 
Figure 21 – Days of school missed by age group 
 
Quality of Life 
Quality of life was assessed using the Paediatric Quality of Life Inventory (PedsQL) with both children and 
parents rating the child’s quality of life. Total and subscale average scores at referral are shown in Table 
8, with higher scores reflecting greater quality of life. Total scores below 69.7 and 65.4 for the child and 
parent, respectively, indicate ‘at risk’ status for impaired quality of life. Over 85% of both parents and 
children rated the child’s quality of life in this ‘at risk’ range. 
Table 7 – Patient and parent quality of life scores 
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Psychosocial 53.7 51.0 
Physical 38.9 38.4 
Total score 48.4 46.5 
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Disability 
Children aged eight and older completed the Functional Disability Inventory (FDI) to assess the impact of 
pain on the ability to complete 15 regular physical activities (such as walking, going to school, getting to 
sleep). The average score for children was 23.1, reflecting moderate disability. The distribution of scores 
by severity category is shown in Figure 22, indicating that over 4 in 5 children rated their functional 
disability as either moderate or severe. 
 
Figure 22 – Disability at referral by severity category 
 
Pain-related anxiety 
Children aged 13 and older completed the pain-specific anxiety section of the Bath Adolescent Pain 
Questionnaire. This asks questions assessing pain-related worries, such as “I avoid activities that cause 
pain” and “When I have pain, I think something harmful is happening”. Responses range from Never to 
Always, with higher scores indicating greater severity. Children scored an average of 15.9 in pain-specific 
anxiety. The distribution of scores on this tool is shown below in Figure 23. 
 
Figure 23 – Distribution of pain-related worry scores  
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Medication use 
Parents provided information regarding the medication their child was taking for pain and how 
frequently each was used. The percent of patients taking each medication type daily or often is shown in 
Figure 24 below. 
 
Figure 24 – Percentage of patients using medication daily or often by medication type
  
 
 
Health service utilisation  
Parents reported how many times in the past three months their child had used various health services 
and had diagnostic tests performed because of their pain, shown in Table 8. These equate to, on average, 
more than one visit every week for pain-related reasons. 
 
Table 8 – Paediatric patient use of health services 
Health service Mean 
General practitioner 3.3 
Medical specialist 2.9 
Allied health professionals  3.1 
Other therapist 1.4 
Hospital emergency department 1.3 
Hospital admission 0.4 
Diagnostic tests 2.0 
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The episode of care 
In paediatric services, the median wait time was 49 days (average = 65 days). This reflects the time from 
when the pain service receives a referral, to the first clinical contact. 85% of people were seen within 3 
months of the service receiving the referral. 
Episodes of care tended to be longer in paediatric services (compared to adult pain services), with a 
median episode length of 183 days. 
 
 
Patient outcomes 
Pain management units provided information on outcomes reported by 101 patients and 94 parents for 
episodes that ended during 2018.  
Pain and quality of life 
Although the volume of outcomes is relatively small, a large proportion of children and adolescents (and their 
parents) reported clinically significant improvement3 after receiving pain management at specialist services (see  
Table 9). 
 
Table 9 – Paediatric patient outcomes 
 
Percent of patients reporting a clinically significant 
improvement Patient rated Parent rated 
Pain Severity   
Average pain 62% 65% 
Worst pain 42% 53% 
Health-related quality of life   
Sleep 45% 39% 
Overall 76% 75% 
Functional disability 61% na 
 
Average pain improved in around 2 in 3 children, as did functional ability. An even higher proportion of 
patients and parents reported clinically significant improvement in overall health-related quality of life, 
with over 3 in 4 children improving.  
There was also a reduction in the percentage of children whose scores on the PedsQL indicated impaired 
quality of life: at referral 84% of children were classified as having impaired quality of life, however at the 
end of the episode of care this proportion was 55%. 
One in two adolescents reported an improvement of 30% or more in their pain-related anxiety.  
 
  
                                                                
3 In assessing outcomes using the standard assessment tools, ePPOC has adopted guidelines for 
determining whether a change is clinically significant, that is, what change in score represents a 
meaningful difference to the patient. These guidelines are detailed in Appendix C. 
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Medication use 
The change in frequent use of medications from referral to episode end is shown in Figure 25. With the 
exception of opioids not containing codeine, there was a reduction in the use of medications used daily 
or often. 
 
Figure 25 – Medications used daily or often at referral compared to episode end 
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Appendix A – Data submitting services 
Adult pain management services 
New South Wales 
Central Coast Integrated Pain Service 
Concord Repatriation Hospital Pain Clinic 
Greenwich Hospital Pain Management Service 
Hunter Integrated Pain Service 
Illawarra-Shoalhaven Chronic Pain Service 
Lismore Hospital Pain Management Clinic 
Liverpool Hospital Chronic Pain Service 
Nepean Hospital Pain Management Unit 
Orange Base Hospital Chronic Pain Clinic 
Port Macquarie Chronic Pain Service 
Prince of Wales Pain Management Department 
Royal North Shore Hospital Pain Service 
Royal Prince Alfred Pain Management Service 
St George Pain Management Unit 
St Vincent’s Hospital Pain Clinic 
Sydney Spine and Pain Rehab 
Tamworth Integrated Pain Service 
Westmead Hospital Pain Service 
 
Queensland 
Interventus Pain Specialists 
North Queensland Persistent Pain Management 
Service (Townsville Hospital) 
Princess Alexandra Hospital – Metro South Health 
Persistent Pain Management Service 
St Vincent’s Private Hospital Brisbane 
Sunshine Coast Persistent Pain Management 
Service (Nambour Hospital) 
The Wesley Hospital Brisbane 
 
South Australia 
Central Adelaide Local Health Network 
Flinders Medical Centre Pain Management Unit 
Northern Pain Rehabilitation Service 
 
Western Australia 
Fiona Stanley Hospital 
PainCare 
Sir Charles Gairdner Hospital 
 
Victoria 
Advance Healthcare 
Austin Health 
Barbara Walker Centre for Pain Management 
Caulfield Pain Management and Research Centre 
Dorset Rehabilitation Centre 
Eastern Health Pain Management Service 
Empower Rehab 
Epworth Hospital 
Goulburn Valley Chronic Pain Service  
Latrobe Regional Hospital 
Melbourne Health – Pain Management Services 
Monash Health Pain Management 
Northern Health Pain Assessment & Management 
Service 
Peninsula Health Chronic Pain Management Service 
Precision Ascend Rehabilitation Centre 
The Victorian Rehabilitation Centre 
Western Health Pain Management 
 
New Zealand 
Active Plus 
Advantage South 
APM Workcare 
Body in Motion 
Canterbury DHB (Burwood Hospital) 
Capital and Coast DHB (Wellington) 
Fit For Work 
Futureproof Rehab 
Habit Group 
Hutt Valley DHB 
Integrative Pain Care 
Nelson Nursing Service 
Occupational Health Canterbury 
Pain Management and Rehabilitation Services Ltd 
Pain Rehabilitation Christchurch Ltd 
Proactive Health 
QE Health 
Southern Rehab 
Taranaki DHB 
TBI Health 
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Paediatric pain management services 
New South Wales 
Children’s Hospital at Westmead 
John Hunter Children’s Hospital 
Sydney Children’s Hospital Randwick 
 
Queensland 
Queensland Children’s Hospital 
St Vincent’s Private Hospital Brisbane 
 
South Australia 
Women’s and Children’s Hospital Adelaide 
Victoria 
Monash Children’s Hospital 
Royal Children’s Hospital Melbourne 
 
New Zealand 
Starship Children’s Hospital Auckland 
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Appendix B – ePPOC assessment tools 
The assessment tools used in ePPOC are: 
• Brief Pain Inventory (BPI) 
• Depression, Anxiety, Stress Scale (DASS) 
• Pain Catastrophising Scale (PCS) 
• Pain Self-Efficacy Questionnaire (PSEQ) 
• Global Rating of Change (GRC) 
• Work Productivity and Impairment (WPAI) 
• CARRA Body Chart. 
Each of these assessment tools are briefly described below. 
Brief Pain Inventory4 
The BPI items used in the ePPOC dataset measure the severity of pain and the degree to which the pain 
interferes with common activities of daily living. There are four pain severity questions, rated on a scale 
of 0 to 10, where 0 = ‘No pain’ and 10 = ‘Pain as bad as you can imagine’. Patients are asked to rate their 
average, worst and least pain over the last week, and their pain right now. Pain severity is calculated as 
an average of these four items.  
Severity bands for these items are: 
• 0-4 = mild pain 
• 5-6 = moderate pain 
• 7-10 = severe pain 
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales 
are that a change of:  
≥ 10% represents minimally important change 
≥ 30% represents moderate clinically important change (ePPOC uses this category to identify 
clinically significant improvement for average and worst pain) 
≥ 50% represents substantial clinically important change. 
The interference questions are rated on a scale of 0 to 10, where 0 = ‘Does not interfere’ and  
10 = ‘Completely interferes’. The interference subscale is an average of the seven interference questions.  
At least 4 of 7 questions must be completed for this subscale to be valid. The IMMPACT recommendation 
for assessment of clinically significant change on the BPI interference scale is a change of 1 point over the 
average of the 7 items5. 
  
                                                                
4 Modified Brief Pain Inventory, reproduced with acknowledgement of the Pain Research Group, University of Texas, 
MD Anderson Cancer Centre, USA 
5 Dworkin, RH, et al 2008, ‘Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: 
IMMPACT Recommendations.’ The Journal of Pain, vol. 9, no. 2, pp 105-121. 
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Depression Anxiety Stress Scales (DASS)6 
The DASS measures the negative emotional states of depression, anxiety and stress. Due to the large 
number of questions in the full DASS (42 questions), the DASS21 is administered. This comprises 21 
questions which are rated on a scale of 0 to 3, where 0 = ‘did not apply to me at all’, 1 = ‘applied to me to 
some degree, or some of the time’, 2 = ‘applied to me to a considerable degree, or a good part of the 
time’, or 3 = ‘applied to me very much, or most of the time’. Scores are multiplied by 2 to enable 
comparison with the full-scale DASS42 for which norms exist. 
For each subscale (Depression, Anxiety and Stress), the 7 items are summed and then multiplied by 2. 
The test developers suggest that at least 6 of 7 items should be complete for each subscale to be 
considered valid. Table 10 shows the range of scores associated with severity categories for each 
subscale. 
Table 10 DASS severity categories 
 Depression Anxiety Stress 
Normal 0-9 0-7 0-14 
Mild 10-13 8-9 15-18 
Moderate 14-20 10-14 19-25 
Severe 21-27 15-19 26-33 
Extremely Severe 28+ 20+ 34+ 
 
Clinical significance on each of the DASS subscales is defined as a change of 5 or more points coupled 
with a move to a different severity category.  
Pain Catastrophising Scale (PCS)7 
The PCS measures a patient’s thoughts and feelings related to their pain. This includes three subscales 
measuring the dimensions of Rumination, Magnification and Helplessness. The PCS comprises 13 
questions (Rumination – 4 items, Magnification – 3 items, Helplessness – 6 items) which are rated on a 
scale of 0 to 4, where 0 = ‘not at all’, 1 = ‘to a slight degree’, 2 = ‘to a moderate degree’, 3 = ‘to a great 
degree’ and 4 = ‘all the time’. For each subscale, all items must be completed to be valid. For the total to 
be valid, at least 12 of 13 items must be completed. 
Severity bands for the PCS are: 
• <20 = mild 
• 20 to 30 = high 
• >30 = severe. 
Clinically significant change requires a change in score of 6 or more points, combined with movement to a 
different severity category8.  
                                                                
6 Lovibond, SH and Lovibond, PF 1995, Manual for the Depression Anxiety Stress Scales, Psychology Foundation 
Monograph, Sydney, Australia. 
7 Sullivan, MJL, et al 1995, ‘The Pain Catastrophizing Scale: Development and Validation’, Psychological Assessment, 
vol. 7, num. 4, pp 524-532. 
8 Sullivan, MJL, personal communication with Nicholas, MK July 2014. 
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Pain Self-Efficacy Questionnaire (PSEQ)9 
The PSEQ measures how confident a patient is that he or she can do a range of activities despite their 
pain. The PSEQ Total is a sum of scores from 10 questions which are rated on a scale from 0 = ‘Not 
confident at all’ to 6 = ‘Completely confident’. At least 9 of 10 items must be complete for the PSEQ Total 
to be valid. Higher scores represent greater pain self-efficacy.  
Severity bands for the PSEQ are: 
• <20 = severe 
• 20 to 30 = moderate 
• 31 to 40 = mild 
• >40 = minimal impairment. 
Clinically significant change is defined as a change in score of 7 or more points, combined with movement 
to a different severity category10.  
Global Rating of Change11 
The Global Rating of Change questions were included as part of the ePPOC dataset in 2018. They are 
asked in follow-up questionnaires only. The two questions are “Compared with before receiving 
treatment at this pain management service, how would you describe yourself now overall?” and 
“Compared with before receiving treatment at this pain management service, how would you describe 
your physical abilities now?” Participants answer by indicating their response on a Likert scale from -3 
(very much worse) to +3 (very much better).  
Work Productivity and Impairment (WPAI)12 
WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater 
impairment and less productivity. The work status of all patients is collected, based on the International 
Consortium for Health Outcomes Measurement (ICHOM) categories. For patients who are employed,  
the WPAI items allow calculation of the following outcomes: 
• % of time missed from work due to pain (absenteeism) 
• % work impairment while working due to pain (lost productivity) 
• % overall work impairment due to pain (taking into account absenteeism and lost 
productivity). 
For more information on the calculations used please see the ePPOC Australian and New Zealand Data 
Dictionaries on the ePPOC website https://ahsri.uow.edu.au/eppoc/forms. 
  
                                                                
9 Nicholas, MK 1989, ‘Self-efficacy and chronic pain’, British Psychological Society, St. Andrews, Scotland. 
10 Nicholas, MK, personal communication, July 2014. 
11 Bartlett, A, Flett, P, Tardif, H and Hush, J 2017, Introducing a global measure of function and change in NSW pain 
services, 37th ASM of the Australian Pain Society, Adelaide, Australia. 
12 Reilly MC, Zbrozek AS, Dukes E 1993, ‘The validity and reproducibility of a work productivity and activity 
impairment measure’, PharmacoEconomics, vol. 4, num. 5, pp 353-365. 
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CARRA Body Chart13 
Patients identify the site/s they feel pain using body maps. For reporting, pain sites are categorised into 
pain areas as follows: 
Pain sites  
Head head and face 
Neck neck 
Chest chest 
Back upper back, mid back and low back  
Leg left and right thighs, left and right calves, left and right ankles 
Arm/shoulder 
left and right shoulders, left and right upper arms, left and right elbows, left and 
right forearms, left and right wrists 
Abdomen abdomen 
Hands left and right hands 
Feet left and right feet 
Pelvic groin 
Knee left and right knees 
Hip left and right hips 
 
 
 
  
                                                                
13 Von Bayer CL, et al. 2011, ‘Pain charts (body maps or manikins) in assessment of location of paediatric pain’, Pain 
Management, vol. 1 num. 1, pp 61-68. (Source: Childhood Arthritis and Rheumatology Research Alliance, 
www.carragroup.org) 
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Appendix C – PaedePPOC assessment 
tools 
Six standardised assessment tools have been chosen to measure patient outcomes and the impact of the 
child’s pain on the parent/parent:  
 
• Modified Brief Pain Inventory - Pain severity questions 
• Faces of Pain Scale – Revised  
• Paediatric Quality of Life Inventory (PedsQL)  
• Functional Disability Inventory (FDI)  
• Bath Adolescent Pain – Pain-specific anxiety  
• Bath Adolescent Pain – Parent Impact Questionnaire (BAP-PIQ)  
Pain Severity 
The tool used to capture pain severity is dependent on the patient’s age. Children aged eight and above 
use the Modified Brief Pain Inventory14, whereas those aged 5-7 use the Faces of Pain Scale-Revised15.  
 
MODIFIED BRIEF PAIN INVENTORY (BPI) - Modified versions of the questions in the standard BPI are used 
to assess pain in children aged eight and over, and obtain a parent proxy rating of the child’s pain for all 
age groups.  
 
FACES PAIN SCALE – REVISED - Children choose one of six faces showing increasing levels of pain, from 
‘no pain’ to ‘very much pain’ which correspond numerically to 0, 2, 4, 6, 8, 10.  
 
For both tools, questions are rated on a scale of 0 (‘No pain’) to 10 (‘Pain as bad as you can imagine’), 
with patients asked their average, worst and least pain over the last week, and their pain right now. 
Severity bands for these items are: 
• 0-4 = mild pain 
• 5-6 = moderate pain 
• 7-10 = severe pain 
 
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales 
are that a change of:  
≥ 10% represents minimally important change  
≥ 30% represents moderate clinically important change  
≥ 50% represents substantial clinically important change.  
 
To determine whether the change experienced by patients at referral is clinically significant, the 
improvement must be at least moderately clinically important, i.e. at least a 30% improvement. 
                                                                
14 Modified Brief Pain Inventory, reproduced with acknowledgement of the Pain Research Group, University of Texas, 
MD Anderson Cancer Centre, USA 
15 Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale—Revised: toward a 
common metric in pediatric pain measurement. PAIN, 2001;93:173–83. 
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Paediatric Quality of Life Inventory (PedsQL)16  
PaedePPOC uses the PedsQL Generic Core Scales to measure health-related quality of life. Parents and all 
patients complete the age-appropriate version. Items are rated on a five point scale where 0=’Never’ [a 
problem] and 4=’Almost always’ [a problem]. For 5-7 year olds the scale is clinician administered and 
rated on a three point scale where 0=’Never’ [a problem], 2=’Sometimes’ [a problem] and 4=’Almost 
always’ [a problem].  
 
Results are reported as four scale scores (physical, emotional, social and school functioning) and two 
summary scores (psychosocial and physical health), with higher scores indicating better health-related 
quality of life.  
 
Minimal clinically meaningful difference on the PedsQL is measured as a: 
• 4.4 change in the child self-report total score 
• 4.5 change in adult proxy-report total score. 
 
For the PedsQL ‘Sleep’ item, clinically significant improvement is reported for patients with trouble 
sleeping at least sometimes (sleep item score = 2). The improvement is classed as clinically significant if 
the score for sleep is reduced by at least 50%. 
 
Functional Disability Inventory (FDI)17  
The FDI is a 15 item assessment tool which asks patients whether they have had any physical trouble or 
difficulty doing specified activities. Items are rated on a five point scale where 0=’No trouble’ and 
4=’Impossible’.  
 
Severity bands for the FDI are:  
• 0-12 = No/minimal disability  
• 13-29 = Moderate disability  
• >29 = Severe disability  
 
Clinically significant change is defined as a change of 5 or more points coupled with a change to a 
different severity category. 
  
                                                                
16 Varni JW, Burwinkle TM, Seid M. The PedsQL as a pediatric patient-reported outcome: reliability and validity of the 
PedsQL measurement model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res 2005;5:705–18. 
17 Walker LS, Greene JW. The Functional Disability Inventory (FDI): measuring a neglected dimension of child health 
status. J Paediatric Psychol 1991;16:39–58. 
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Bath Adolescent Pain Questionnaire – Pain-specific anxiety18  
Section 5 of the BAPQ asks patients about specific worries or concerns they have about their pain. There 
are seven items rated on a five point scale of ‘Never’ to ‘Always’.  
Bath Adolescent Pain – Parent Impact Questionnaire19 
The impact of the child’s pain on the parent is measured over eight subscales: depression, anxiety, child-
related catastrophising, self-blame and helplessness, partner relationship, leisure functioning, parental 
behaviour and parental strain. All items are rated on a 5 point scale, ranging from 0 (never) to 4 (always).  
 
 
                                                                
18 Eccleston C, Jordan A, McCracken LM, Sleed M, Connell H, Clinch J. The Bath Adolescent Pain Questionnaire 
(BAPQ): development and preliminary psychometric evaluation of an instrument to assess the impact of chronic pain 
on adolescents. PAIN 2005;118:263–70. 
19 Jordan A, Eccleston C, McCracken LM, Connell H, Clinch J. The Bath Adolescent Pain—Parental Impact 
Questionnaire (BAP-PIQ): development and preliminary psychometric evaluation of an instrument to assess the 
impact of parenting an adolescent with chronic pain. PAIN, 2008;137:478–87. 
